MAIA Biotechnology Receives USAN Council Approval for “Ateganosine” as Nonproprietary Name for Anticancer Agent THIO
Portfolio Pulse from
MAIA Biotechnology has received approval from the USAN Council for 'Ateganosine' as the nonproprietary name for its anticancer agent THIO.
March 19, 2025 | 3:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
MAIA Biotechnology's anticancer agent THIO has been assigned the nonproprietary name 'Ateganosine' by the USAN Council, marking a regulatory milestone.
The approval of a nonproprietary name by the USAN Council is a significant regulatory step for MAIA Biotechnology's anticancer agent THIO, potentially increasing its recognition and credibility in the market.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100